Welcome to our dedicated page for Astrana Health news (Ticker: ASTH), a resource for investors and traders seeking the latest updates and insights on Astrana Health stock.
Astrana Health Inc. reports developments in physician-centric, technology-enabled healthcare management, including its care delivery infrastructure, proprietary technology platform, and aligned provider networks. The company describes a payer-agnostic, risk-bearing care model designed around coordinated, preventive care and population health management.
Recurring news themes include quarterly and annual financial results, medical cost performance, full-risk contract activity, integration of completed acquisitions, investor-conference presentations, and updates involving governance, capital structure, and operating performance. Company materials also discuss its Care Partners, Care Delivery, and Care Enablement segments.
Astrana Health (NASDAQ: ASTH) reported second quarter 2026 revenue of $972.5 million, up 49% year-over-year, with Care Partners revenue of $932.8 million up 48%. Net income attributable to Astrana rose to $19.7 million and diluted EPS to $0.40, increases of 109% and 111%, respectively. Adjusted EBITDA reached $68.9 million, up 43%, and adjusted diluted EPS was $0.80, up 45%.
For the first six months of 2026, revenue was $1.94 billion (+52%), adjusted EBITDA $135.2 million (+60%), and free cash flow $92.9 million. Operating cash flow was $100.8 million. Astrana guided Q3 2026 revenue to $1.00–$1.03 billion and adjusted EBITDA to $72.5–$77.5 million, and raised full‑year 2026 adjusted EBITDA guidance to $255–$280 million while reaffirming full‑year revenue of $3.8–$4.1 billion and free cash flow of $105–$132.5 million. The company also highlighted $120.4 million in 2024 ACO gross shared savings and continued expansion of its Medicare Advantage footprint.
Astrana Health (NASDAQ: ASTH) will release its 2026 second quarter financial results for the period ended June 30, 2026 after the market close on Thursday, August 6, 2026. The company will host a conference call at 2:30 p.m. PT / 5:30 p.m. ET, with phone dial-in, webcast access, and an accompanying slide presentation available via its investor relations website.
Astrana Health (NASDAQ: ASTH) appointed Daniel Rothman as President of Physician Enterprise and Vishal Gupta as Senior Vice President of Enterprise Transformation, effective as the company advances its physician-centric, AI-enabled value-based care platform.
Rothman, a 20+ year healthcare operator and co-founder of New York-based value-based group Rendr, will lead Astrana's physician enterprise, focusing on growth, operational capabilities, and nationwide provider network expansion. Gupta, a long-time EY partner with over 20 years advising public and high-growth companies on financial reporting, controls, and transactions, will oversee enterprise transformation initiatives across finance, operations, and reporting and analytics to support Astrana's long-term strategy.
Astrana Health (NASDAQ: ASTH) reported that its eight affiliated Accountable Care Organizations generated $120.4 million in gross shared savings in the 2024 performance year. All eight ACOs produced net shared savings, including five in MSSP and three in ACO REACH, serving nearly 100,000 Medicare beneficiaries.
Astrana highlighted that Astrana Care Partners ACO (A5450) ranked 7th of 476 MSSP ACOs nationwide in net shared savings per beneficiary in its first year. The company supports over 20,000 providers and about 1.55 million patients, reported $3.18 billion of fiscal 2025 revenue and $205.4 million adjusted EBITDA, and grew revenue 56% year over year in Q1 2026.
Astrana Health (NASDAQ: ASTH) was named to the 2026 Fortune 1000, its first appearance on the list of the largest U.S. companies by revenue. In fiscal 2025, revenue reached $3.18 billion, a 56% year-over-year increase.
Astrana reported $205.4 million adjusted EBITDA and $104.5 million free cash flow. The company supports more than 20,000 providers and about 1.55 million patients in value-based care arrangements using AI-enabled, physician-centric care models.
Astrana Health (NASDAQ: ASTH) appointed George Christides, M.D. as Interim National Medical Director, effective May 12, 2026. He will oversee population health, care management, and care navigation initiatives across Astrana’s national platform.
Dr. Christides brings 20+ years of clinical and healthcare leadership experience in value-based care and managed care operations.
Astrana Health (NASDAQ: ASTH) and the Physician Association of California announced a collaboration to support independent primary care physicians using Astrana's AI-powered Medicare ACO platform.
The partnership offers PAC physicians integrated care delivery, data, and financial infrastructure, aiming to improve outcomes, ease administrative burden, and enable participation in value-based care.
Astrana Health (NASDAQ: ASTH) reported Q1 2026 results: total revenue $965.1M (+56% YoY), adjusted EBITDA $66.3M (+82% YoY), net income $14.4M (+116% YoY) and free cash flow $64.1M (+372% YoY). The company said ~80% of Care Partners capitation revenue and ~40% of consolidated membership are now in full-risk arrangements. Guidance reiterated for 2026: total revenue $3.8B–$4.1B and adjusted EBITDA $250M–$280M; Q2 revenue guidance $965M–$1,000M and adjusted EBITDA $65M–$70M.
Astrana Health (NASDAQ: ASTH) will release first quarter 2026 financial results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. The company will host a conference call the same day at 2:30 p.m. PT / 5:30 p.m. ET to discuss results.
Dial-in numbers are 877-858-9810 and +1 201-689-8517. A PDF slide presentation will be posted on the company’s IR Calendar and a live webcast plus recording will be available via the provided webcast link.
Astrana Health (NASDAQ: ASTH) announced that company leadership will participate in three upcoming investor conferences: the Needham Virtual Healthcare Conference (April 13-16, 2026), the Bank of America Global Healthcare Conference (May 12-14, 2026) with a fireside chat on May 12 at 3:40pm PT, and the William Blair Growth Stock Conference (June 2-4, 2026) with a fireside chat on June 3 at 4:00pm CT.
Webcast links and presentation materials will be posted in the IR Calendar on the company website.